Hexima

Hexima EBIT Margin

The EBIT Margin (Operating Margin) of Hexima (HXL.AX) as of Oct 17, 2026 is -223.46 %. In the previous year, EBIT Margin (Operating Margin) was -170.47 % — a change of 31.08% (lower).

EBIT Margin

-223.46 %

YoY

31.08%

Last updated:

EBIT Margin (Operating Margin) of Hexima is 2023 -223.46 % . EBIT Margin (Operating Margin) of Hexima was 2022 -170.47 % . It decreases by 31.08% lower compared to the previous year.

For Hexima, the operating (EBIT) margin of -223.5% is up versus -686.6% a few years ago.

The Hexima EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2016
-211.85 AUD
Jan 1, 2017
6.93 AUD
Jan 1, 2018
-3.66 AUD
Jan 1, 2019
-686.61 AUD
Jan 1, 2020
-6,752.55 AUD
Jan 1, 2021
-164.78 AUD
Jan 1, 2022
-170.47 AUD
Jan 1, 2023
-223.46 AUD
The Hexima EBIT Margin history
YEAREBIT MarginYoY
-223.46 %+31.08%
-170.47 %+3.45%
-164.78 %-97.56%
-6,752.55 %+883.47%
-686.61 %+18,638.95%
-3.66 %-152.87%
6.93 %-103.27%
-211.85 %+389.06%
-43.32 %-27.43%
-59.70 %+5,884.42%
-1.00 %-81.49%
-5.39 %-36.46%
-8.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hexima Stock analysis

What does Hexima do? Hexima Ltd, based in Melbourne, Australia, operates in the Health Care sector within the Biotechnology industry. The company focuses on researching and developing plant defensin peptides for human therapeutics, with its lead candidate pezadeftide targeting fungal nail infections. Hexima is conducting phase II clinical trials for pezadeftide as a treatment for onychomycosis, leveraging its Antifungal Plant Defensin Technology platform to identify antifungal peptides effective against various human fungal pathogens. Listed on 1 December 2020, the company explores applications of its technology for additional fungal diseases. Hexima is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hexima stock

EBIT Margin (Operating Margin) of Hexima is -223.46 % in 2023.

EBIT Margin (Operating Margin) of Hexima changed from -170.47 % to -223.46 %, representing a 31.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Hexima since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Hexima with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Hexima

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Hexima